Welcome to our dedicated page for SkyAI SEC filings (Ticker: SKYAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SkyAI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SkyAI's regulatory disclosures and financial reporting.
SkyAI, Inc. received an amended Schedule 13G from Bastion Trading Limited, Bastion Holdings Limited, Lucio Holding Limited and Wei Zhu reporting their beneficial ownership. As of August 13, 2026, Wei Zhu is reported as beneficially owning 4,294,891 shares of SkyAI common stock, representing a capped 9.99% interest. Bastion Trading and Bastion Holdings each report beneficial ownership of 1,354,816 shares (about 3.2% each), and Lucio Holding reports 2,940,075 shares (about 6.8%). The ownership includes 1,345,417 common shares, pre-funded warrants exercisable for up to 4,234,615 shares and stapled warrants exercisable for up to 5,384,615 shares, subject to Beneficial Ownership Blockers limiting post-exercise ownership to 9.99% of outstanding common stock. Percentages are based on 42,982,506 shares outstanding as of August 4, 2026, plus 9,399 warrant shares exercisable within 60 days for certain holders.
Saba Capital Management, L.P., together with Saba Capital Management GP, LLC and Boaz R. Weinstein, reports beneficial ownership of 3,050,450 shares of SkyAI, Inc. common stock and warrants, representing 6.85% of the class. The percentage is based on 42,982,506 shares outstanding as of August 4, 2026 plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting parties. Voting and dispositive powers over these shares are reported as shared, with no sole voting or dispositive power. Funds and accounts advised by Saba Capital have the right to receive dividends and sale proceeds from the common stock.
SkyAI, Inc. reported unaudited results for the three and six months ended June 30, 2026. For the first half of 2026, the company recorded a net loss from continuing operations of $109,520,033, compared with income from continuing operations of $7,769,654 a year earlier, primarily reflecting losses on its Solana ("SOL") treasury holdings.
Staking revenue from SOL was $5,457,656 for the six-month period, but this was outweighed by an unrealized loss on digital commodities of $84,336,553 and a realized loss of $14,716,799. Legacy medical device net revenue was $192,780, with activity focused on sales and distribution after manufacturing was discontinued in 2025.
At June 30, 2026, SkyAI held 2,003,676 SOL with a cost basis of $381,570,910 and a fair value of $144,282,193, plus cash of $12,071,008. Total liabilities were $3,070,440 against stockholders’ equity of $157,280,135. Under its 2025 repurchase program, 1,213,669 shares had been bought back into treasury at a cost of $2,011,573.
SkyAI, Inc., a Nevada corporation listed on the Nasdaq Capital Market, reports that its board formed a special committee of independent directors to evaluate an unsolicited, non-binding proposal from Forward Industries, Inc. for a potential all-stock business combination.
After completing this review, both the special committee and the full board unanimously concluded that the proposal was not in the best interests of SkyAI shareholders. The company states that it is not pursuing this transaction at this time.
SkyAI, Inc., formerly Sharps Technology, Inc., has amended its Nevada articles of incorporation to change its corporate name and align with a new AI-driven strategy. Its common stock now trades on Nasdaq under the ticker SKYA and its warrants under SKYAW, replacing STSS and STSSW. The company is pivoting from its legacy operations to build an agentic finance platform for the Global South, combining artificial intelligence with blockchain-based infrastructure, including stablecoin rails and the Solana network. It has opened an operational headquarters in Hong Kong to support licensing, hiring and regional expansion, and discloses extensive operational, legal, regulatory, cybersecurity and competitive risks tied to its AI and digital asset-focused strategy, including evolving AI regulation such as the EU’s AI Act.
SkyAI, Inc. entered into an employment agreement with Arthur Levine and appointed him as its Chief Financial Officer, effective May 22, 2026. Levine, age 68, had been serving as interim CFO since February 2026 and has extensive prior CFO experience at public companies.
Under the agreement, he will receive a base salary of $400,000 per year and is eligible for an annual cash bonus equal to 50% of base salary, contingent on performance and continued employment. He will also be considered for additional equity-based awards at the board’s discretion.
If SkyAI terminates him without cause or he resigns for good reason, he is entitled to severance equal to one times base salary and accelerated vesting of outstanding equity, subject to a release. If such a termination occurs in connection with a change in control, cash severance increases to three times base salary, with equity also accelerating.
Sharps Technology, Inc. (STSS) — Schedule 13G/A amendment reporting beneficial ownership by Saba Capital and related persons. The amendment states the Reporting Persons share voting and dispositive power over 3,050,450 shares, representing 6.95% of the class based on 42,322,168 shares outstanding as of May 8, 2026 plus 1,538,462 shares issuable upon exercise of certain warrants. The filing identifies Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein as joint filers and notes the funds and accounts advised by Saba Capital have rights to dividends and sale proceeds.
Sharps Technology, Inc. reporting persons filed an amended Schedule 13G/A disclosing shared beneficial ownership positions in the company's common stock as of May 15, 2026.
The filing lists aggregate holdings including 4,355,147 shares attributable to Wei Zhu (capped at 9.99% by warrant blockers) and shows a disclosed outstanding share base of 42,322,168 shares as of May 8, 2026. The filing states pre-funded warrants exercisable for 4,234,615 shares and stapled warrants exercisable for 5,384,615 shares held by Bastion Trading.
Sharps Technology reported a sharp swing to loss in the quarter ended March 31, 2026 as its new digital commodity treasury strategy dominated results. Net revenue from medical devices was modest at $192,780, while staking revenue from Solana-based holdings contributed $3.1 million.
The company recorded an unrealized loss on digital commodities of $70.8 million and a realized loss of $10.8 million, driving a net loss of $86.2 million, or $1.19 per share, compared with net income a year earlier. Fair value of SOL holdings fell to $162.5 million from $250.1 million at December 31, 2025, despite maintaining over 2.0 million SOL tokens.
Cash increased to $12.3 million as SOL sales and staking inflows outweighed operating and financing outflows. The company repurchased 867,678 shares for about $1.6 million and ended the quarter with stockholders’ equity of $178.8 million against minimal liabilities. Segment reporting now separates medical devices from the digital commodity treasury, underscoring the strategic pivot toward Solana-based assets.
Sharps Technology, Inc. details a major strategic pivot in its annual report, combining its legacy syringe distribution business with a new, SOL-focused digital asset treasury strategy funded by an approximately $400 million PIPE.
The company reports holding over 2,000,000 SOL, intends to stake up to 95% of its SOL, and uses multiple qualified custodians. It incurred a $282.5 million net loss in 2025, versus $9.3 million in 2024, leading to an accumulated deficit of $316.9 million. Sharps also launched a large at-the-market equity program and a $100 million share repurchase authorization, while entering a 20-year consulting agreement tied to the value of its digital assets.